跳至主要内容
临床试验/CTRI/2026/01/101042
CTRI/2026/01/101042尚未招募3 期

A controlled clinical study to evaluate the effect of Lashuntaila over Kumaritaila uttarabasti in the management of vandhytwa w.s.r to Tubal blockage.

Dr Dharmi raval1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年1月28日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1

研究概览

简要总结

Since the beginning of time human infertility has been a source of personal misery. Infertility is inability to conceive within one or more years of regular unprotected coitus.

Around 17.5 percentage of the adult population roughly 1 in 6 worldwide experience infertility, showing the urgent need to increase access to affordable, high-quality fertility care. According to modern science, there are 5 main factors responsible for infertility i.e.

Tubal disease (25 to 30 percentage)

Ovulatory dysfunction (30 to 40 percentage)

Uterine factor (10 percentage)

Cervical factor (5 percentage)

Pelvic endometriosis (1to 10 percentage)

Tubal factor as the causes of female infertility which includes; Peritubal adhesions, Endosalpingeal damage, Salpingitis isthemica nodosa, Tubal endometriosis, Tubal spasm,

Polyps/Mucous debris with tubal lumen, Previous tubal surgery or sterilization. In modern science, there are surgeries like Tubal microsurgery, Laparoscopic tubal adhesiolysis, Fimbrioplasty and tubal surgery, Tubal cannulation etc for the tubal blockage but these modalities have their own demerits. so, directly they refer to IVF. The chief among the

adverse effect is failure of surgery and high incidence of ectopic pregnancy in post treatment cases. There failure rate is more than success rate. So, it is great scope of research to find out safe, potent, cost-effective treatment from ayurveda for the management of tubal blockage. In Ayurvedic classics, there are so many factors described which are essential for fertility, out of which Acharya Sushrut has described 4 factors i.e. Rutu, Kshetra, Ambu, Beeja. Among these 4, Kshetra factor has prime role i.e., the female reproductive system.

In present era, Vandhytwa has been one of the unsolved major complaints of women hood. Acharya Kashyapa in Kashyapa Samhita have mentioned about the lashuna born from nectar and it is rasayana (rejuvenating). The breasts of women never fall (become lax) by daily use of lashuna, neither their beauty nor progeny and strength or longevity decreases. Their fortune increases and youth becomes stable. We can corelate Tubal blockage with Srotosanga, as to clear the Srotosanga we can use Ushna, Tikshna dravyas.

In present study, Lashun taila mentioned in Kashyap Samhita for the treatment of vandhytwa containing lashun is selected having Ushana, Tikshna, Rasayana, Vata-kaphahara,

Vrsya properties. By the virtue of Tikshna Ushna gunas of Lashun srotosanga can be relieved. Acharya Sushruta has considered Tila Taila as Yonishula Prashamana & Garbhashayashodhana. It is Sara, Vyavayi, Vikasi, Krimighna & Vranaghna. All these Gunas make it a suitable medium, as it may itself act to open the blockage. Its Vyavayi, Vikasi & Sara Guna may improve the availability of drugs on target organs. So, these properties may be helpful to clear the tubal blockage.Hence, the present study is taken up to evaluate the effect of Lashun taila in Tubal blockage.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • 1.Woman diagnosed with Tubal blockage.
  • 2.Both the patients having primary & secondary 3.female infertility included.
  • Patients between age group of 20 to 45 year.

排除标准

  • 1.Patients having any urogenital infection were excluded from study.
  • (PID, Pelvic tuberculosis, more etc.) 2.Patients suffering from any chronic debilitating disease like STD, Hepatitis B, Contagious disease etc.
  • were also excluded from the study.
  • 3.Patients having any congenital anomalies of uterus, ovaries and fallopian tubes were excluded from the study.
  • 4.Patients having Uterine fibroids [subserosal & submucosal] more than 3cm.

研究者

发起方
Dr Dharmi raval
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DrDharmi kamleshkumar raval

shree jagadguru gavisiddheshwara ayurvedic medical college koppal

研究点 (1)

Loading locations...

相似试验